Literature DB >> 35037026

hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapy.

Yong Lu1,2, Gang Xue1, Ningbo Zheng1, Kun Han1, Wenzhong Yang3, Rui-Sheng Wang4, Lingyun Wu5, Lance D Miller2,6, Timothy Pardee2,7, Pierre L Triozzi2,7, Hui-Wen Lo2,6, Kounosuke Watabe2,6, Stephen T C Wong8, Boris C Pasche2,6, Wei Zhang2,6, Guangxu Jin2,6.   

Abstract

There is a lack of robust generalizable predictive biomarkers of response to immune checkpoint blockade in multiple types of cancer. We develop hDirect-MAP, an algorithm that maps T cells into a shared high-dimensional (HD) expression space of diverse T cell functional signatures in which cells group by the common T cell phenotypes rather than dimensional reduced features or a distorted view of these features. Using projection-free single-cell modeling, hDirect-MAP first removed a large group of cells that did not contribute to response and then clearly distinguished T cells into response-specific subpopulations that were defined by critical T cell functional markers of strong differential expression patterns. We found that these grouped cells cannot be distinguished by dimensional-reduction algorithms but are blended by diluted expression patterns. Moreover, these identified response-specific T cell subpopulations enabled a generalizable prediction by their HD metrics. Tested using five single-cell RNA-seq or mass cytometry datasets from basal cell carcinoma, squamous cell carcinoma and melanoma, hDirect-MAP demonstrated common response-specific T cell phenotypes that defined a generalizable and accurate predictive biomarker.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Pareto optimization; projection-free single-cell modeling; response to immune checkpoint blockade; single-cell RNA sequencing (scRNA-seq); single-cell mass cytometry (CyTOF)

Mesh:

Substances:

Year:  2022        PMID: 35037026      PMCID: PMC8921624          DOI: 10.1093/bib/bbab575

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  49 in total

1.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

2.  Molecular signatures database (MSigDB) 3.0.

Authors:  Arthur Liberzon; Aravind Subramanian; Reid Pinchback; Helga Thorvaldsdóttir; Pablo Tamayo; Jill P Mesirov
Journal:  Bioinformatics       Date:  2011-05-05       Impact factor: 6.937

3.  Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.

Authors:  Spencer C Wei; Jacob H Levine; Alexandria P Cogdill; Yang Zhao; Nana-Ama A S Anang; Miles C Andrews; Padmanee Sharma; Jing Wang; Jennifer A Wargo; Dana Pe'er; James P Allison
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

4.  Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.

Authors:  Brian C Miller; Debattama R Sen; Rose Al Abosy; Kevin Bi; Yamini V Virkud; Martin W LaFleur; Kathleen B Yates; Ana Lako; Kristen Felt; Girish S Naik; Michael Manos; Evisa Gjini; Juhi R Kuchroo; Jeffrey J Ishizuka; Jenna L Collier; Gabriel K Griffin; Seth Maleri; Dawn E Comstock; Sarah A Weiss; Flavian D Brown; Arpit Panda; Margaret D Zimmer; Robert T Manguso; F Stephen Hodi; Scott J Rodig; Arlene H Sharpe; W Nicholas Haining
Journal:  Nat Immunol       Date:  2019-02-18       Impact factor: 25.606

5.  TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.

Authors:  Joe-Marc Chauvin; Ornella Pagliano; Julien Fourcade; Zhaojun Sun; Hong Wang; Cindy Sander; John M Kirkwood; Tseng-hui Timothy Chen; Mark Maurer; Alan J Korman; Hassane M Zarour
Journal:  J Clin Invest       Date:  2015-04-13       Impact factor: 14.808

6.  Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.

Authors:  Lukas Baitsch; Petra Baumgaertner; Estelle Devêvre; Sunil K Raghav; Amandine Legat; Leticia Barba; Sébastien Wieckowski; Hanifa Bouzourene; Bart Deplancke; Pedro Romero; Nathalie Rufer; Daniel E Speiser
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

7.  Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis.

Authors:  Jacob H Levine; Erin F Simonds; Sean C Bendall; Kara L Davis; El-ad D Amir; Michelle D Tadmor; Oren Litvin; Harris G Fienberg; Astraea Jager; Eli R Zunder; Rachel Finck; Amanda L Gedman; Ina Radtke; James R Downing; Dana Pe'er; Garry P Nolan
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

8.  Statistical significance of variables driving systematic variation in high-dimensional data.

Authors:  Neo Christopher Chung; John D Storey
Journal:  Bioinformatics       Date:  2014-10-21       Impact factor: 6.937

9.  Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients.

Authors:  Priyanka B Subrahmanyam; Zhiwan Dong; Daniel Gusenleitner; Anita Giobbie-Hurder; Mariano Severgnini; Jun Zhou; Michael Manos; Lauren M Eastman; Holden T Maecker; F Stephen Hodi
Journal:  J Immunother Cancer       Date:  2018-03-06       Impact factor: 13.751

10.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.